In the video below, Motley Fool health-care analyst Max Macaluso takes a question from a Fool reader, who asks, "What do you think of AbbVie (ABBV 3.76%)?"
Free Article
You're reading a free article with opinions that may differ from The Motley Fool's Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More
Ask a Fool: What Do You Think About AbbVie?
By Max Macaluso
–
May 30, 2013 at 7:50PM
NYSE: ABBV
AbbVie
Market Cap
$394B
Today's Change
(3.76%) $8.39
Current Price
$231.55
Price as of September 30, 2025, 3:58 p.m. ET
AbbVie has generated a lot of buzz in the pharmaceuticals space ever since it spun off from Abbott Labs. What do we think of it here at the Fool?
About the Author
Max is the Technology, Biopharma & Health Care Bureau Chief at Fool.com. Prior to joining the Fool, he completed a PhD in chemistry at the University of Cambridge and an MBA at the College des Ingenieurs.
Max Macaluso, Ph.D. and The Motley Fool have no position in any stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.
Stocks Mentioned
AbbVie
ABBV
$231.55
(3.76%)
$8.39
*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.
Related Articles
5 Dividend Powerhouses to Buy and Never Sell
3 Top Dividend Stocks to Buy and Hold Forever
Where Will AbbVie Be in 5 Years?
1 Top Dividend Stock to Buy and Hold Forever
What Is One of the Best Pharmaceutical Stocks to Buy Right Now?
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.